Stockscreener 앱 받기
24.33
0.41%
-0.10
시간 외 거래:
24.33
전일 마감가:
$24.43
열려 있는:
$24.49
하루 거래량:
1.46M
Relative Volume:
1.09
시가총액:
$2.15B
수익:
$172.60M
순이익/손실:
$-285.42M
주가수익비율:
-7.381
EPS:
-3.2963
순현금흐름:
$-323.17M
1주 성능:
-0.94%
1개월 성능:
+3.53%
6개월 성능:
+61.77%
1년 성능:
+114.74%
1일 변동 폭
$23.88
$24.73
1주일 범위
$23.88
$25.21
52주 변동 폭
$8.58
$25.59
Syndax Pharmaceuticals Inc Stock (SNDX) Company Profile
명칭
Syndax Pharmaceuticals Inc
전화
781-419-1400
주소
730 THIRD AVENUE, NEW YORK, MA
Compare SNDX vs VRTX, REGN, ARGX, ALNY, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
SNDX
Syndax Pharmaceuticals Inc
|
24.33 | 2.15B | 172.60M | -285.42M | -323.17M | -3.2963 |
VRTX
Vertex Pharmaceuticals Inc
|
441.70 | 113.01B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
753.93 | 79.87B | 14.34B | 4.50B | 3.77B | 41.56 |
ARGX
Argen X Se Adr
|
840.87 | 51.51B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
333.39 | 45.29B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
319.94 | 34.41B | 5.36B | 287.73M | 924.18M | 2.5229 |
Syndax Pharmaceuticals Inc Stock (SNDX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-10-16 | 재개 | H.C. Wainwright | Buy |
| 2025-09-10 | 재개 | Stifel | Buy |
| 2025-09-04 | 재개 | Guggenheim | Buy |
| 2025-08-05 | 재확인 | BTIG Research | Buy |
| 2025-07-10 | 개시 | Goldman | Buy |
| 2024-10-24 | 개시 | UBS | Buy |
| 2024-06-28 | 개시 | Jefferies | Buy |
| 2024-01-31 | 다운그레이드 | Scotiabank | Sector Outperform → Sector Perform |
| 2023-12-22 | 개시 | Mizuho | Buy |
| 2023-10-25 | 개시 | BofA Securities | Buy |
| 2023-10-11 | 개시 | Goldman | Buy |
| 2023-07-27 | 개시 | Scotiabank | Sector Outperform |
| 2023-07-11 | 개시 | Guggenheim | Buy |
| 2023-04-17 | 재개 | BTIG Research | Buy |
| 2023-01-31 | 개시 | Stifel | Buy |
| 2023-01-03 | 개시 | JP Morgan | Overweight |
| 2022-07-28 | 재개 | B. Riley Securities | Buy |
| 2022-04-11 | 개시 | H.C. Wainwright | Buy |
| 2022-02-15 | 개시 | Goldman | Buy |
| 2021-06-04 | 재개 | Robert W. Baird | Outperform |
| 2021-05-25 | 개시 | Citigroup | Buy |
| 2021-02-18 | 개시 | B. Riley Securities | Buy |
| 2020-12-03 | 개시 | Stifel | Buy |
| 2020-05-22 | 업그레이드 | Citigroup | Neutral → Buy |
| 2020-05-22 | 다운그레이드 | H.C. Wainwright | Buy → Neutral |
| 2020-05-18 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2020-05-11 | 재확인 | H.C. Wainwright | Buy |
| 2020-03-04 | 개시 | Barclays | Overweight |
| 2020-01-13 | 재확인 | H.C. Wainwright | Buy |
| 2019-03-08 | 재확인 | H.C. Wainwright | Buy |
| 2019-01-04 | 개시 | Robert W. Baird | Outperform |
| 2018-01-05 | 개시 | B. Riley FBR, Inc. | Buy |
| 2017-03-16 | 개시 | FBR & Co. | Outperform |
| 2017-03-02 | 개시 | Instinet | Buy |
| 2016-10-07 | 개시 | Guggenheim | Buy |
| 2016-03-28 | 개시 | Citigroup | Buy |
| 2016-03-28 | 개시 | JMP Securities | Mkt Outperform |
| 2016-03-28 | 개시 | Morgan Stanley | Overweight |
모두보기
Syndax Pharmaceuticals Inc 주식(SNDX)의 최신 뉴스
Liquidity Mapping Around (SNDX) Price Events - Stock Traders Daily
SNDX 260417 21.00C (SNDX260417C21000) Stock Options Chain | Quotes & News - Moomoo
SNDX SEC FilingsSyndax Pharmaceuticals Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Syndax Pharmaceuticals Inc at JPMorgan Healthcare Conference Transcript - GuruFocus
SNDX Should I Buy - Intellectia AI
Update Recap: Can Syndax Pharmaceuticals Inc disrupt its industryRate Hike & Precise Swing Trade Alerts - baoquankhu1.vn
Syndax Pharmaceuticals Hits New 52-Week High - National Today
Syndax Pharmaceuticals (NASDAQ:SNDX) Reaches New 52-Week HighShould You Buy? - MarketBeat
Palumbo Wealth Management LLC Invests $1.08 Million in Syndax Pharmaceuticals, Inc. $SNDX - MarketBeat
BTIG Raises Syndax Pharmaceuticals (SNDX) PT to $56 Following Strong Q2 Revenue from Revuforj, Niktimvo - MSN
Syndax Pharmaceuticals, Inc.'s (NASDAQ:SNDX) Path To Profitability - 富途牛牛
US Market Wrap: Is Syndax Pharmaceuticals Inc a defensive stock2026 Buyback Activity & Consistent Return Investment Signals - baoquankhu1.vn
SNDX Technical Analysis & Stock Price Forecast - Intellectia AI
Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - Sahm
SG Americas Securities LLC Has $2.72 Million Stock Position in Syndax Pharmaceuticals, Inc. $SNDX - MarketBeat
Syndax Pharmaceuticals Inc (1T3.MU) Analyst Insights, Price Targets & Recommendations - ca.finance.yahoo.com
Goldman Sachs Raises Price Target for SNDX to $34, Maintains 'Bu - GuruFocus
Syndax Pharmaceuticals (NASDAQ:SNDX) Stock Price Expected to Rise, The Goldman Sachs Group Analyst Says - MarketBeat
Why (SNDX) Price Action Is Critical for Tactical Trading - Stock Traders Daily
Goldman Sachs Maintains Syndax Pharmaceuticals(SNDX.US) With Buy Rating, Maintains Target Price $34 - Moomoo
SNDX Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
Syndax Pharmaceuticals, Inc. $SNDX Shares Sold by Assenagon Asset Management S.A. - MarketBeat
MACD Signal: What makes Syndax Pharmaceuticals Inc stock attractive today2026 Recap & Consistent Profit Trade Alerts - baoquankhu1.vn
SNDX Analyst Rating Update: Mizuho Lowers Price Target | SNDX St - GuruFocus
Mizuho Securities Maintains Syndax Pharmaceuticals(SNDX.US) With Buy Rating, Cuts Target Price to $43 - Moomoo
Syndax Pharmaceuticals (NASDAQ:SNDX) Price Target Cut to $43.00 by Analysts at Mizuho - MarketBeat
Hennion & Walsh Asset Management Inc. Grows Stake in Syndax Pharmaceuticals, Inc. $SNDX - MarketBeat
Entry Recap: Is Syndax Pharmaceuticals Inc a good ESG investment2026 Price Momentum & Free Expert Verified Stock Movement Alerts - baoquankhu1.vn
SNDX: Jefferies Adjusts Syndax Pharmaceuticals Price Target to $40 | SNDX Stock News - GuruFocus
Jefferies Financial Group Reiterates "Buy" Rating for Syndax Pharmaceuticals (NASDAQ:SNDX) - MarketBeat
Mizuho lowers Syndax Pharmaceuticals stock price target on sales timing By Investing.com - Investing.com Canada
Syndax Pharmaceuticals Inc (1T3.SG) Analyst Insights, Price Targets & Recommendations - Yahoo! Finance Canada
Jefferies cuts Syndax Pharmaceuticals stock price target on valuation By Investing.com - Investing.com Canada
Vanguard (NYSE) reports 0 shares in Syndax after realignment (SNDX) - Stock Titan
Syndax (SNDX) Q4 2025 Earnings Call Transcript - AOL.com
Syndax Pharmaceuticals Inc (NASDAQ:SNDX) Emerges as a High-Growth Momentum Pick Using Minervini's Trend Template - ChartMill
Syndax Pharmaceuticals (NASDAQ:SNDX) Hits New 12-Month HighWhat's Next? - MarketBeat
Earnings call transcript: Syndax Pharmaceuticals Q4 2025 revenue beats forecast, stock rises - Investing.com Canada
Hedge Fund Bets: Is Syndax Pharmaceuticals Inc stock showing strong momentumMarket Trend Summary & Daily Price Action Insights - baoquankhu1.vn
Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat
Syndax Pharmaceuticals, Inc. $SNDX Shares Sold by Hudson Bay Capital Management LP - MarketBeat
CEO Moves: Can Syndax Pharmaceuticals Inc stock double in the next yearMarket Activity Report & Community Verified Watchlist Alerts - baoquankhu1.vn
Biotech Stock Up 72% Sees $8 Million Sale, but Here's Why One Fund Still Seems Bullish - AOL.com
This Biotech Stock Winner Is Up 72%, but a $4 Million Trim Signals a Slight Reset - AOL.com
DAFNA Capital Reduces Syndax Pharmaceuticals Holding in Q4 2025News and Statistics - IndexBox
Kynam Capital Sells $8.18M in Syndax Shares, Position Value RisesNews and Statistics - IndexBox
Biotech Shares Surge 72% with $8 Million Transaction, Yet This Is Why a Fund Remains Optimistic - Bitget
Understanding Momentum Shifts in (SNDX) - Stock Traders Daily
Syndax Pharmaceuticals stock hits 52-week high at 25.16 USD By Investing.com - Investing.com Canada
Can Syndax Pharmaceuticals Inc scale operations efficiently2026 News Drivers & Fast Moving Stock Watchlists - baoquankhu1.vn
Syndax Pharmaceuticals Inc (SNDX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.69%
0.25%
자본화:
|
볼륨(24시간):